Will NVIDIA Return to Its 52-Week High?
NVIDIA (NASDAQ:NVDA) has been among the best-performing investments of the…
Sell
12
GEHC Quote, Financials, Valuation and Earnings
Last price:
$62.80
Seasonality move
:
-6.81%
Day range:
$60.86 - $63.60
52-week range:
$57.65 - $94.80
Dividend yield:
0.2%
P/E ratio:
14.51x
P/S ratio:
1.47x
P/B ratio:
3.40x
Volume:
7.2M
Avg. volume:
4.9M
1-year change:
-28.79%
Market cap:
$28.7B
Revenue:
$19.7B
EPS (TTM):
$4.33
GEHC Analysts' Consensus Rating
The 17 analysts providing 12-month price projections for GE HealthCare Technologies shares anticipate an average target of $100.23, ranging from a low estimate of $74.00 to a high estimate of $115.00. This average target implies a growth of 59.57% compared to the current stock price of $62.81.
Consensus Price Target
$100.23
Highest Price Target
$115.00
Lowest Price Target
$74.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 10 | 12 | 12 |
| Hold | 7 | 4 | 4 |
| Sell | 1 | 1 | 1 |
| Consensus | Buy | Buy | Buy |
GEHC Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
